Qiagen NV (QGEN)
45.24
+0.22
(+0.49%)
USD |
NYSE |
Sep 27, 16:00
45.24
0.00 (0.00%)
After-Hours: 20:00
Qiagen Revenue (Annual): 1.965B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.965B |
| December 31, 2022 | 2.142B |
| December 31, 2021 | 2.252B |
| December 31, 2020 | 1.870B |
| December 31, 2019 | 1.526B |
| December 31, 2018 | 1.502B |
| December 31, 2017 | 1.418B |
| December 31, 2016 | 1.338B |
| December 31, 2015 | 1.281B |
| December 31, 2014 | 1.345B |
| December 31, 2013 | 1.302B |
| December 31, 2012 | 1.254B |
| December 31, 2011 | 1.170B |
| December 31, 2010 | 1.087B |
| December 31, 2009 | 1.010B |
| Date | Value |
|---|---|
| December 31, 2008 | 892.98M |
| December 31, 2007 | 649.77M |
| December 31, 2006 | 465.78M |
| December 31, 2005 | 398.40M |
| December 31, 2004 | 380.63M |
| December 31, 2003 | 351.40M |
| December 31, 2002 | 298.61M |
| December 31, 2001 | 263.77M |
| December 31, 2000 | 216.80M |
| December 31, 1999 | 158.16M |
| December 31, 1998 | 120.80M |
| December 31, 1997 | 74.27M |
| December 31, 1996 | 54.20M |
| December 31, 1995 | 37.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.526B
Minimum
2019
2.252B
Maximum
2021
1.951B
Average
1.965B
Median
2023
Revenue (Annual) Benchmarks
| LENZ Therapeutics Inc | 15.00M |
| Oruka Therapeutics Inc | -- |
| Thermo Fisher Scientific Inc | 42.86B |
| uniQure NV | 15.84M |
| ProQR Therapeutics NV | 7.052M |